A phase 1, open-label, randomized, two-way crossover study to evaluate the effect of multiple doses of fidaxomicin on the single dose pharmacokinetics of rosuvastatin in healthy male subjects

Trial Profile

A phase 1, open-label, randomized, two-way crossover study to evaluate the effect of multiple doses of fidaxomicin on the single dose pharmacokinetics of rosuvastatin in healthy male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Fidaxomicin (Primary) ; Rosuvastatin (Primary)
  • Indications Clostridium infections
  • Focus Pharmacokinetics
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 14 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top